• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Pie Medical Imaging Launches AI-Powered Echocardiography Platform

Article

CAAS Qardia 2.0, an updated version of the CAAS Qardia echocardiography software platform, reportedly incorporates artificial intelligence (AI)-enabled workflows, and provides enhanced imaging and analysis of key cardiac measures.

Combining off-cart echocardiography analysis with artificial intelligence (AI) capabilities, Pie Medical Imaging has launched the FDA-cleared CAAS Qardia 2.0 platform.

An update to the company’s CAAS Qardia echocardiography software, the CAAS Qardia 2.0 software offers robust visualization of stress-echo imaging and diastolic function, and reportedly excels at analysis of myocardial strain and other cardiac assessments, according to Pie Medical Imaging.

The company notes that quality control indices with the CAAS Qardia 2.0 platform enable clinicians to counteract potential foreshortening of cardiac imaging that may impact measurements such as myocardial strain. Leveraging AI-powered workflows, the CAAS Qardia 2.0 software generates automated reporting of key parameters.

Pie Medical imaging adds that the CAAS Qardia software can be server-based with access from any PC within a hospital network or be deployed in a stand-alone setup.

(Editor's note: For a related article, see "FDA Clears AI-Powered Echocardiography Platform for Detecting Heart Failure with Preserved Ejection Fraction.")

Recent Videos
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Nina Kottler, MD, MS
Related Content
© 2025 MJH Life Sciences

All rights reserved.